Vaccine For Omicron

Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.

The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.

Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.

The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.

Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.

The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.

A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.

US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.

Amazon has updated its policy following the availability of COVID-19 vaccines and revised guidance from the US’ Centers for Disease Control and Prevention.

People who are vaccinated and have had a booster shot against Covid-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.

A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.

Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.

The government credited wide vaccination coverage for a fall in the number of deaths. "Active case numbers and corresponding deaths are much lower in this wave," it said and pointed out that the severity of infections is also relatively lower.

Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.

Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.

The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.

Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.

The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.

Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.

The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.

A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.

US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.

Amazon has updated its policy following the availability of COVID-19 vaccines and revised guidance from the US’ Centers for Disease Control and Prevention.

People who are vaccinated and have had a booster shot against Covid-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.

A fourth dose of existing mRNA Covid-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.

Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.

The government credited wide vaccination coverage for a fall in the number of deaths. "Active case numbers and corresponding deaths are much lower in this wave," it said and pointed out that the severity of infections is also relatively lower.

Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.